We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

An Exploratory Study of the Effects of a Single Dose of QAX576 (an Interleukin-13 Monoclonal Antibody) on Simulated Hayfever

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00584584
Recruitment Status : Completed
First Posted : January 2, 2008
Last Update Posted : February 24, 2017
Information provided by:

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : August 2008
  Study Completion Date : No date given